Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > ME 23andMe > Company Profile
ME 23andMe
3.050
+0.240+8.54%
Post Mkt Price
3.000
-0.050-1.64%
Symbol
ME
Company Name
23andMe
Listing Date
06/17/2021
Establishment Date
2006
CEO
Ms. Anne Wojcicki
Market
NASDAQ
Employees
768
Securities Type
DR
Fiscal Year Ends
03-31
Address
349 Oyster Point Boulevard
City
South San Francisco
Province
California
Country
United States of America
Zip code
94080
Phone
1-650-938-6300
Profile
23andMe Holding Co. is consumer genetics and research company, which engages to help people access, understand, and benefit from the human genome. It provides direct access to genetic information with multiple Food and Drug Administration authorizations for genetic health risk reports. The company operates under the Consumer and Research Services segment, and the Therapeutics segment. The firm’s research platform has generated publications on the genetic underpinnings of a range of diseases, conditions, and traits. The platform also powers the 23andMe therapeutics group, pursuing drug discovery programs rooted in human genetics across a spectrum of disease areas, including oncology, respiratory, and cardiovascular diseases, in addition to other therapeutic areas. The company was founded by Anne E. Wojcickiin 2006 and is headquartered in South San Francisco, CA.
Company Overview
23andMe Holding Co. is consumer genetics and research company, which engages to help people access, understand, and benefit from the human genome. It provides direct access to genetic information with multiple Food and Drug Administration authorizations for genetic health risk reports. The company operates under the Consumer and Research Services segment, and the Therapeutics segment. The firm’s research platform has generated publications on the genetic underpinnings of a range of diseases, conditions, and traits. The platform also powers the 23andMe therapeutics group, pursuing drug discovery programs rooted in human genetics across a spectrum of disease areas, including oncology, respiratory, and cardiovascular diseases, in addition to other therapeutic areas. The company was founded by Anne E. Wojcickiin 2006 and is headquartered in South San Francisco, CA.
CEO: Ms. Anne Wojcicki
Market: NASDAQ
Listing Date: 06/17/2021
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist